Neuralink
Products: neuro-robot. Risk band: Elevated RobotRisk index 37.7/100 (severity- and time-weighted incidents) · ranked 6 of 25 among Medical robotics companies with incidents (173 tracked).
Analyst brief
The record contains two entries: a 2024 malfunction in which brain-implant threads retracted in the first human trial patient, and a 2022 federal inquiry into animal deaths during preclinical implant testing. Severity is 3 and 4 respectively, and the two entries span both a device-performance malfunction in human use and a federal investigative action tied to earlier preclinical work. Neuralink's index of 37.7 ranks 6 of 25 companies in Medical robotics with incident history. The record shows two distinct failure types at different stages of development (preclinical animal testing and first-in-human deployment) rather than a single repeated fault.
Risk index
Incident timeline
Comparisons over time
Per-type breakdown
| Incident type | Unique incidents | Share |
|---|---|---|
| malfunction | 1 | 50% |
| fatality | 1 | 50% |
Unique incident list
2 unique incidents on file for this company.
| Sev | Date | Type | Location | Incident | Source |
|---|---|---|---|---|---|
| S3 | 08 May 2024 | malfunction | — | Neuralink brain implant threads retract in first human patient | CBS News |
| S4 | not documented | fatality | — | Federal inquiry into Neuralink over animal deaths in implant testing | The Guardian |
S3 08 May 2024 · malfunction · Neuralink brain implant threads retract in first human patient
| Sev | Date | Supporting source row | Source |
|---|---|---|---|
| S3 | 08 May 2024 | Neuralink brain implant threads retract in first human patient | CBS News |
S4 not documented · fatality · Federal inquiry into Neuralink over animal deaths in implant testing
| Sev | Date | Supporting source row | Source |
|---|---|---|---|
| S4 | not documented | Federal inquiry into Neuralink over animal deaths in implant testing | The Guardian |
Similar companies
Same industry, nearest RobotRisk band or score.